Compounds > deltorphin ii, ala(2)-

Page last updated: 2024-09-03

deltorphin ii, ala(2)- and norbinaltorphimine

deltorphin ii, ala(2)- has been researched along with norbinaltorphimine in 7 studies

Compound Research Comparison

Studies (deltorphin ii, ala(2)-)	Trials (deltorphin ii, ala(2)-)	Recent Studies (post-2010) (deltorphin ii, ala(2)-)	Studies (norbinaltorphimine)	Trials (norbinaltorphimine)	Recent Studies (post-2010) (norbinaltorphimine)
6	0	2	918	0	205
233	0	20	918	0	205

Protein Interaction Comparison

Protein	Taxonomy	deltorphin ii, ala(2)- (IC50)	norbinaltorphimine (IC50)
Delta-type opioid receptor	Mus musculus (house mouse)		0.0104
Kappa-type opioid receptor	Mus musculus (house mouse)		0.0029
Mu-type opioid receptor	Homo sapiens (human)		0.212
Delta-type opioid receptor	Homo sapiens (human)		0.024
Kappa-type opioid receptor	Homo sapiens (human)		0.0036

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	5 (71.43)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adapa, ID; Auh, JS; Berzetei-Gurske, IP; Brandt, SR; Craymer, K; Farrington, L; Haggart, D; Kennedy, JM; O'Brien, A; Polgar, WE; Rodriguez, L; Schwartz, RW; Toll, L; White, A	1
Adler, MW; Cowan, A; Eisenstein, TK; Gaughan, J; Geller, EB; Meissler, JJ; Rahim, RT; Rogers, TJ	1
Arvidsson, U; Kela, J; Salmi, P; Wahlestedt, C	1
Lunzer, MM; Portoghese, PS	1
Fujimura, T; Ito, K; Kawamura, S; Mizoguchi, H; Murayama, K; Nakayama, D; Sakurada, C; Sakurada, S; Sakurada, T; Sato, T; Watanabe, C; Watanabe, H	1
Bidlack, JM; Parkhill, AL	1
Ansonoff, MA; Pintar, JE; Portoghese, PS	1

Other Studies

7 other study(ies) available for deltorphin ii, ala(2)- and norbinaltorphimine

Article	Year
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. NIDA research monograph, 1998, Volume: 178 Topics: Animals; Aorta, Thoracic; Cocaine; Cyclic AMP; Electric Stimulation; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Male; Mice; Muscle, Smooth; Opioid-Related Disorders; Rats; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin; Substance-Related Disorders	1998
Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses. International immunopharmacology, 2001, Volume: 1, Issue:11 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Antibody Formation; Depression, Chemical; Dose-Response Relationship, Drug; Female; Immunosuppressive Agents; Infusion Pumps; Mice; Mice, Inbred C3H; Morphine; Naltrexone; Neuroimmunomodulation; Oligopeptides; Osmosis; Peptide Fragments; Peptides; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Somatostatin; Spleen	2001
Functional interactions between delta- and mu-opioid receptors in rat thermoregulation. European journal of pharmacology, 2003, Jan-01, Volume: 458, Issue:1-2 Topics: Animals; Body Temperature; Body Temperature Regulation; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptors, Opioid, delta; Receptors, Opioid, mu	2003
Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord. European journal of pharmacology, 2003, Apr-25, Volume: 467, Issue:1-3 Topics: Animals; Benzylidene Compounds; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Immune Sera; Mice; Naltrexone; Oligopeptides; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Somatostatin; Spinal Cord	2003
A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 312, Issue:3 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Male; Mice; MSH Release-Inhibiting Hormone; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Receptors, Opioid, mu	2005
Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line. International immunopharmacology, 2006, Volume: 6, Issue:6 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Cell Line, Tumor; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Gene Expression; Interleukin-6; Lipopolysaccharides; Mice; Monocytes; Naltrexone; Narcotic Antagonists; Oligopeptides; Receptors, Opioid, kappa; RNA Stability; Time Factors; Transcription, Genetic; Tumor Necrosis Factor-alpha	2006
Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands. Psychopharmacology, 2010, Volume: 210, Issue:2 Topics: Amides; Animals; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Guanidines; Ligands; Male; Mice; Mice, Knockout; Naltrexone; Oligopeptides; Pain; Protein Multimerization; Receptors, Opioid, delta; Receptors, Opioid, kappa	2010